Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma

BACKGROUND: Apatinib, a vascular endothelial growth factor receptor 2 (VEGFR-2) inhibitor, has shown promising therapeutic effect for hepatocellular carcinoma (HCC). This prospective clinical study was implemented to evaluate the efficacy and safety of apatinib combined with transarterial chemoembol...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Transl Med
Главные авторы: Gu, Huiying, Li, Jing, You, Nan, Wu, Ke, Wang, Zheng, Wang, Liang, Zhu, Yinan, Liu, Qinqin, Peng, Xuehui, Zheng, Lu
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2020
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812192/
https://ncbi.nlm.nih.gov/pubmed/33490189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-7244
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы